Graves' Disease: Clinical Trials

4 trials for Graves' Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting, 1 recruiting, 1 unknown. 4 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 1, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 23Completed 1, Not yet recruiting 1, Unknown 1

Follow Graves' Disease: new trials by email Literature Review of Graves' Disease trials Research Report on Graves' Disease

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Open-Label Study to Determine if BHV-1300 is Safe in Adults With Graves' Disease
BHV-1300 - Graves' Disease
Phase 2 / Phase 3Not yet recruitingBiohaven Therapeutics Ltd.3562026-10-012026-10-28
A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease
Efgartigimod PH20 SC, Placebo PH20 SC - Graves' Disease, Graves Disease
Phase 3Recruitingargenx2302026-06-102026-10-16
Graves' Disease Remission Study: MycoMeth Combo
Mycophenolate Mofetil, Oral, 250 Mg, methimazole, oral, 10mg - Graves' Disease
Phase 2 / Phase 3UnknownThe First Affiliated Hospital of Xiamen University2052023-10-162024-02-28
Early Levothyroxine Post Radioactive Iodine
Levothyroxine, Placebo - Graves' Disease
Phase 2 / Phase 3CompletedMayo Clinic612013-09-012019-10-29

Narrower conditions

Graves Disease (4)  ·  Hyperthyroidism (1)  ·  Hypothyroidism (1)

Broader conditions

Autoimmune Diseases (4)  ·  Endocrine System Diseases (4)  ·  Exophthalmos (4)  ·  Eye Diseases (4)  ·  Goiter (4)  ·  Immune System Diseases (4)  ·  Orbital Diseases (4)  ·  Thyroid Diseases (4)  ·  Hyperthyroidism (3)

Interventions

Methimazole (1)  ·  Mycophenolic Acid (1)  ·  Thyroid Hormones (1)  ·  Thyroxine (1)

Sponsors

Biohaven Therapeutics Ltd. (1)  ·  Mayo Clinic (1)  ·  The First Affiliated Hospital of Xiamen University (1)  ·  argenx (1)

Countries

United States (2)  ·  China (1)  ·  Georgia (1)

Top investigators

Fangsen Xiao, MD (1)  ·  Marius Stan, MD (1)

Results publications

PMID 26670972, PMID 27272078, PMID 27521067, PMID 27797318, PMID 29396246, PMID 30912336, PMID 32055040, PMID 32616746, PMID 32929476, PMID 34598995, PMID 35223896, PMID 35959915, PMID 36346684

NIH funding

2025 (1)